|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177,400 KRW | -1.17% |
|
+0.17% | -11.96% |
| Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
| Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
June 27 (Reuters) - Celltrion Inc:
* WINS SALES APPROVAL RECOMMENDATION FOR ITS CT-P16 FROM EUROPEAN MEDICINES AGENCY'S COMMITTEE Further company coverage: (Reporting by ByungwookKim Kim)
| 1st Jan change | Capi. | |
|---|---|---|
| -11.96% | 26.77B | |
| +2.03% | 42.59B | |
| +7.33% | 40.65B | |
| +49.22% | 40.57B | |
| +9.22% | 24.81B | |
| -24.03% | 18.17B | |
| +27.38% | 12.05B | |
| -3.09% | 11.7B | |
| +7.05% | 11.1B | |
| -17.24% | 9.85B |
CELLTRION, INC. 
